Circulating Immune Dynamics During Neoadjuvant Chemoimmunotherapy in Early Triple-negative Breast Cancer
Year: 2026
Type: preprint
Abstract: Background: Pathological complete response (pCR) after pembrolizumab-based neoadjuvant chemoimmunotherapy predicts improved outcomes in early triple-negative breast cancer (TNBC), but circulating immune determinants of response remain poorly characterized. Methods: The study included 64 patients with early TNBC treated with pembrolizumab-based neoadjuvant chemoimmunotherapy. Flow cytometry analyzed 125 peripheral-blood specimens collected at baseline, during treatment and before surgery. Baseline PBMCs from 22 patients underwent scRNA-seq, generating 135,271 quality-controlled cells. Analyses used nonparametric tests, effect sizes, FDR correction and sensitivity analyses. Results: Baseline scRNA-seq identified response-associated transcriptional differences. Patient-level pseudo-bulk analysis revealed enrichment of TNF-alpha/NF-kappaB signaling in cytotoxic T/NK and B cells from non-pCR patients (global q<=3.94e-7), together with MYC targets and mTORC1 signaling in cytotoxic T/NK cells (both global q=7.00e-5). T-cell analyses suggested preserved naive/memory features in pCR, while a higher proportion of CX3CR1-expressing cells within the CD4 memory/activation-like compartment was associated with pCR (q=0.0157; AUC=0.949). In B cells, pCR was associated with a nominally higher naive-like program score (P=0.029; q=0.059), supported by higher IGHM and IGHD signals, whereas XBP1 was higher in non-pCR. Flow cytometry identified treatment-associated B-cell remodeling. At pre-surgery, switched-memory B-cell CD38 balance was higher in pCR than non-pCR patients (62.6% versus 50.0%; P=0.0086; q=0.0667; Cliff's delta=0.651; AUC=0.825) and remained nominally significant in leave-one-patient-out analyses. Early increases in unswitched-memory B-cell CD38 balance were numerically greater in non-pCR patients, whereas pre-surgery switched-memory B-cell CD38 balance was higher in pCR patients. Conclusions: Baseline inflammatory and metabolic pathway enrichment was associated with non-pCR, whereas pCR-associated T-cell findings included a CD4 memory/activation-associated CX3CR1 signal and trends towards preserved naive/memory features. Together with time- and compartment-dependent B-cell remodeling, these findings nominate circulating transcriptional states and CD38-defined B-cell dynamics for prospective validation as candidate biomarkers of pathological response.
Source: medRxiv
Authors: Javier Pascual, Maria Rosario Chica-Parrado, Clotilde Costa, Roberto Pineiro, Maria Elena Quiros-Ortega, Alvaro Gonzalez-Ortiz, Ana Godoy, Maria Emilia Dominguez, Nuria Ribelles, Bella Pajares, Antonia Marquez-Aragones, Begona Jimenez-Rodriguez, Pilar Cantizani, Patricia Palacios-Ozores, Esperanza Lopez-Lopez, Patricia Chaves-Guerrero, Jesus Velasco-Suelto, Maria Victoria Ortega-Jimenez, Maria Isabel Hierro-Martin, Martina Alvarez, Enrique de Alava, Rafael Lopez-Lopez, Emilio Alba, Inaki Comino-Mendez
Institutions: Centro de Investigación Biomédica en Red, Andalusian Centre for Nanomedicine and Biotechnology, Instituto de Investigación Biomédica de Málaga, Instituto de Investigación Sanitaria de Santiago, Centro de Investigación Biomédica en Red de Cáncer, Hospital Clínico Universitario Virgen de la Victoria, Hospital Regional Universitario de Málaga, Complejo Hospitalario Universitario de Santiago, Servicio Gallego de Salud, Universidad de Málaga, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío, Universidad de Sevilla
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Keywords: triple-negative breast cancer, neoadjuvant chemoimmunotherapy, pembrolizumab, pathological complete response, circulating immune cells, peripheral blood mononuclear cells, single-cell RNA sequencing, T cell exhaustion, natural killer cells, CX3CR1, TNF-α/NF-κB signaling, c-Myc, mTORC1, predictive biomarkers
Open Access status: green
OpenAlex ID: W7237208705
